Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this?
Related Articles
Senza categoria
N E W S R O U N D
Impact Factor
Radiation dose for prostate cancer: is more better?
News
Leave a Reply